Fully Automated Cowingene Enterovirus Universal, EV71 and CoxA16 NATBox Detection Kit for Rapid Molecular Diagnosis

Enterovirus infections, particularly those caused by Enterovirus Universal, EV71, and CoxA16, are among the leading causes of hand, foot, and mouth disease (HFMD) and other acute viral illnesses in children. These pathogens can spread rapidly and cause significant public health concerns, especially in densely populated regions. Early and accurate detection is essential for controlling outbreaks and ensuring timely clinical intervention. The Cowingene Enterovirus Universal, EV71 and CoxA16 Detection Kit (NATBox) is designed to provide fully automated, high-sensitivity molecular diagnosis using advanced PCR technology integrated into a closed system platform.

This product is developed by Cowin Gene, a molecular diagnostics company specializing in POCT (Point-of-Care Testing) solutions. Cowin Gene's molecular POCT products provide great convenience to clinicians and patients with their rapid detection time, easy operation procedure, and high sensitivity detection performance. The company’s core product line includes PCR-based diagnostic kits capable of rapidly detecting a wide range of pathogens, including viruses, bacteria, and fungi.

Cowin Gene is supported by a dedicated team of senior scientists, engineers, and marketing experts who are committed to continuous technological innovation and product optimization. Its R&D center is equipped with state-of-the-art laboratory equipment and a strict quality management system to ensure that every product meets international diagnostic standards and delivers reliable and reproducible performance.

High-Precision NATBox System for Simultaneous Detection of Enterovirus, EV71, and CoxA16 in Clinical Testing

The Cowingene Enterovirus Universal, EV71 and CoxA16 Detection Kit (NATBox) is an in vitro diagnostic (IVD) test designed for the qualitative detection of RNA from Enterovirus Universal, EV71, and CoxA16 in patient specimens. It uses Polymerase Chain Reaction (PCR) technology to amplify viral RNA targets and identify multiple pathogens in a single automated analysis.

Unlike conventional molecular diagnostic workflows that require separate steps for nucleic acid extraction, amplification, and detection, the NATBox system integrates all processes into a fully automated platform. This significantly simplifies laboratory operations and reduces the need for manual intervention.

The system is designed to specifically identify Enterovirus Universal, EV71, and CoxA16, allowing clinicians to differentiate between general enterovirus infections and more clinically significant subtypes such as EV71, which is often associated with more severe neurological complications.

Key technical specifications include:

Detection targets: EVU, EV71, CoxA16

Method: PCR amplification with automated detection

Platform: NATBox system

Limit of detection (LoD):

EVU: 400 copies/mL

EV71: 400 copies/mL

CA16: 400 copies/mL

Specimen types: human stool, vomitus

Certification: CE-IVD

Compatible instrument: NATBox® Mini II

The system ensures high analytical performance while maintaining a closed and contamination-resistant workflow, which is essential for infectious disease diagnostics.

Advanced Integrated PCR Solution for Efficient Enterovirus Detection in Modern Laboratories

The NATBox Enterovirus Detection Kit is designed to provide a streamlined, fully integrated molecular diagnostic workflow. The system combines lysis, nucleic acid extraction, PCR amplification, and detection into a single cartridge-based process, reducing operational complexity and improving testing efficiency.

One of the key advantages of this system is its closed-cartridge design. Once the sample is loaded, all subsequent steps are performed automatically within the sealed cartridge, significantly reducing the risk of cross-contamination and human error. This makes it particularly suitable for hospital laboratories, emergency departments, and infectious disease control centers.

Storage and handling requirements are designed to ensure reagent stability and optimal performance:

Storage at 2–8°C for up to 12 months

Transport at 2–8°C for no more than 15 days

Lysis buffer, positive and negative controls stable for 1 month at 2–8°C after opening

Cartridge must be used within 30 minutes after adding lysis buffer

Protect from light exposure

Reagents must be equilibrated at room temperature for 5 minutes before use

Order information:

REF: GI04023W
Product Name: Cowingene Enterovirus Universal, EV71 and CoxA16 Detection Kit
Type: NATBox
Package Size: 24 tests/kit

Recommended supporting reagents:

CW06021Z Cowingene Sample Diluent Reagent (CE, 10 mL/bottle, 10 bottles)

CW07023Q Cowingene NATBox System (CE, 1 unit)

These supporting reagents ensure proper sample preparation and system compatibility, enabling consistent and accurate molecular testing results.

Global Molecular Diagnostics Innovation and Trusted Automated Enterovirus Testing Solution Provider

Cowin Gene is a leading molecular diagnostics company dedicated to advancing PCR-based POCT technologies for infectious disease detection. Its product portfolio covers a broad range of pathogens, including viruses, bacteria, and fungi, enabling comprehensive diagnostic support for clinical laboratories worldwide.

The company’s strength lies in its integrated approach combining scientific research, engineering innovation, and strict quality management systems. Its R&D center is equipped with advanced molecular biology instruments and follows rigorous quality control procedures to ensure product consistency, accuracy, and reliability.

The Cowingene Enterovirus Universal, EV71 and CoxA16 Detection Kit (NATBox) reflects Cowin Gene’s commitment to improving infectious disease diagnostics through automation and precision technology. By integrating all diagnostic steps into a single closed system, the kit significantly improves workflow efficiency while minimizing contamination risk.

In clinical practice, rapid identification of enterovirus infections is essential for outbreak control and patient management. EV71 infections, in particular, are associated with higher risks of severe complications, making accurate differentiation from CoxA16 and other enteroviruses critical for treatment decisions and public health monitoring.

The NATBox platform provides a scalable and efficient solution for laboratories seeking to improve molecular diagnostic capacity while maintaining high accuracy standards. Its compact design and automation capabilities make it suitable for both centralized laboratories and point-of-care testing environments.

In conclusion, the Cowingene Enterovirus Universal, EV71 and CoxA16 Detection Kit (NATBox) is a fully automated, high-precision molecular diagnostic solution. Supported by Cowin Gene’s advanced R&D capabilities and strict quality management system, it enhances diagnostic efficiency, reduces operational complexity, and plays an important role in the rapid detection and control of enterovirus-related infectious diseases worldwide.